The Trend Is Your Friend: Direct Oral Antagonists as Standard Anticoagulants for Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Interventions

被引：0
|
作者：
Nordbeck, Peter [1 ,2 ]
Hu, Kai [1 ,2 ]
机构：
[1] Univ Hosp Wurzburg, Dept Internal Med 1, Wurzburg, Germany
[2] Comprehens Heart Failure Ctr, Wurzburg, Germany
来源：
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY | 2021年 / 77卷 / 02期
关键词：
DABIGATRAN;
D O I：
10.1097/FJC.0000000000000950
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：162 / 163
页数：2
相关论文
共 50 条
  • [1] Inappropriate dosing of direct oral anticoagulants in patients with atrial fibrillation undergoing percutaneous coronary intervention
    Kitahara, H.
    Tanabe, Y.
    Yamazaki, T.
    Hiraga, T.
    Abe, K.
    Kobayashi, Y.
    EUROPEAN HEART JOURNAL, 2024, 45
  • [2] Inappropriate dosing of direct oral anticoagulants in patients with atrial fibrillation undergoing percutaneous coronary intervention
    Kitahara, H.
    Tanabe, Y.
    Yamazaki, T.
    Hiraga, T.
    Abe, K.
    Kobayashi, Y.
    EUROPEAN HEART JOURNAL, 2024, 45
  • [3] Efficacy and safety of direct oral anticoagulants vs. vitamin K antagonists in subgroups of patients with atrial fibrillation undergoing percutaneous coronary intervention
    Casula, Matteo
    Fabris, Francesca
    Leonardi, Sergio
    Ferlini, Marco
    Moscatelli, Sara
    Porto, Italo
    Gnecchi, Massimiliano
    Fortuni, Federico
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2019, 21 (0J) : J35 - J36
  • [4] Impact of Underdosing of Direct Oral Anticoagulants on Clinical Outcomes in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention
    Kitahara, Hideki
    Yamazaki, Tatsuro
    Hiraga, Takashi
    Suzuki, Sakuramaru
    Ohno, Yuji
    Harada, Junya
    Fukushima, Kenichi
    Asano, Tatsuhiko
    Ishio, Naoki
    Uchiyama, Raita
    Miyahara, Hirofumi
    Okino, Shinichi
    Sano, Masanori
    Kuriyama, Nehiro
    Yamamoto, Masashi
    Sakamoto, Naoya
    Kanda, Junji
    Kobayashi, Yoshio
    CIRCULATION JOURNAL, 2025, 89 (02) : 195 - 203
  • [5] Management of Direct Oral Anticoagulants in Patients with Atrial Fibrillation Undergoing Cardioversion
    Coppola, Giuseppe
    Manno, Girolamo
    Mignano, Antonino
    Luparelli, Mirko
    Zarcone, Antonino
    Novo, Giuseppina
    Corrado, Egle
    MEDICINA-LITHUANIA, 2019, 55 (10):
  • [6] Vitamin K Antagonists and Direct Oral Anticoagulants in Nonagenarian Patients With Atrial Fibrillation
    Raposeiras-Roubin, Sergio
    Alonso Rodriguez, David
    Camacho Freire, Santiago Jesus
    Abu-Assi, Emad
    Cobas-Paz, Rafael
    Rodriguez Pascual, Carlos
    Garcia Comesana, Julio
    Gonzalez-Carrero Lopez, Alberto
    Cubelos Fernandez, Naiara
    Lopez-Masjuan Rios, Alvaro
    Cespon-Fernandez, Maria
    Munoz-Pousa, Isabel
    Caneiro-Queija, Berenice
    Rodriguez Albarran, Adrian
    Alvarez Castanera, Sara
    Verisimo Guillen, Julia
    Carpintero Vara, Alberto
    Barreiro Pardal, Cristina
    Dominguez-Erquicia, Pablo
    Manuel Dominguez-Rodriguez, Luis
    Diaz Fernandez, Jose Francisco
    Fernandez Vazquez, Felipe
    Iniguez-Romo, Andres
    JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION, 2020, 21 (03) : 367 - +
  • [7] Thrombocytopenia in Patients With Atrial Fibrillation on Oral Anticoagulation Undergoing Percutaneous Coronary Intervention
    Kiviniemi, Tuomas
    Karjalainen, Pasi
    Rubboli, Andrea
    Schlitt, Axel
    Tuomainen, Petri
    Niemela, Matti
    Laine, Mika
    Biancari, Fausto
    Lip, Gregory Y. H.
    Airaksinen, K. E. Juhani
    AMERICAN JOURNAL OF CARDIOLOGY, 2013, 112 (04): : 493 - 498
  • [8] No antiarrhythmic effect of direct oral anticoagulants versus vitamin K antagonists in paroxysmal atrial fibrillation patients undergoing catheter ablation
    Zweiker, David
    Manninger, Martin
    Sieghartsleitner, Raphael
    Ebner, Jakob
    Pratl, Bernadette
    Bisping, Egbert
    Lercher, Peter
    von Lewinski, Dirk
    Riedlbauer, Rita
    Rohrer, Ursula
    Spronk, Henri M. H.
    Zirlik, Andreas
    Schotten, Ulrich
    Scherr, Daniel
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2021, 331 : 106 - 108
  • [9] Direct Oral Anticoagulants Versus Vitamin K Antagonists in Patients With Atrial Fibrillation After TAVR
    Kawashima, Hideyuki
    Watanabe, Yusuke
    Hioki, Hirofumi
    Kozuma, Ken
    Kataoka, Akihisa
    Nakashima, Makoto
    Nagura, Fukuko
    Nara, Yugo
    Yashima, Fumiaki
    Tada, Norio
    Naganuma, Toru
    Yamawaki, Masahiro
    Yamanaka, Futoshi
    Shirai, Shinichi
    Mizutani, Kazuki
    Tabata, Minoru
    Ueno, Hiroshi
    Takagi, Kensuke
    Yamamoto, Masanori
    Hayashida, Kentaro
    JACC-CARDIOVASCULAR INTERVENTIONS, 2020, 13 (22) : 2587 - 2597
  • [10] Novel oral anticoagulants in patients undergoing cardioversion for atrial fibrillation
    Alexandros Briasoulis
    Anupama Kottam
    Mazhar Khan
    Luis Afonso
    Journal of Thrombosis and Thrombolysis, 2015, 40 : 139 - 143
12345